|
Oct 1
|
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years
|
|
Sep 26
|
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
|
|
Sep 23
|
Evotec opens first European biologics facility in France
|
|
Sep 20
|
Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)
|
|
Jul 31
|
Evotec SE's (ETR:EVT) largest shareholders are retail investors with 48% ownership, institutions own 36%
|
|
Jun 25
|
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
|
|
Jun 12
|
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
|
|
Jun 10
|
Evotec SE: Results of the Annual General Meeting 2024
|
|
Jan 22
|
Evotec SE: Invitation to Conference Call
|
|
Jan 22
|
UPDATE 1-Evotec says it promptly reported share trades withheld by former CEO
|
|
Jan 10
|
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
|
|
Dec 19
|
Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
|
|
Dec 6
|
Evotec-partner Jingxin Receives Approval for EVT201 in China
|
|
Dec 4
|
Evotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%
|
|
Dec 1
|
‘From Hype to Clinical‘: Cowen Suggests 2 AI Healthcare Stocks to Consider
|
|
Nov 15
|
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
|
|
Nov 12
|
Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript
|
|
Nov 8
|
Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
|
|
Nov 7
|
Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
|
|
Nov 7
|
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
|